Generic placeholder image

Cardiovascular & Hematological Disorders-Drug Targets

Editor-in-Chief

ISSN (Print): 1871-529X
ISSN (Online): 2212-4063

Case Report

Bleeding Complication in a Patient with Concomitant Use of Rivaroxaban and Saffron Supplement: A Case Report

Author(s): Zinat Heidari, Maryam Daei, Hossein Khalili and Amirhossein Sahebkar*

Volume 22, Issue 1, 2022

Published on: 29 April, 2022

Page: [10 - 12] Pages: 3

DOI: 10.2174/1871529X22666220418102545

Price: $65

Abstract

Background: Direct oral anticoagulants (DOACs) carry a lower potential risk of food/herb and drug interactions compared to oral vitamin K antagonists. However, as a new class of medications, drug interactions of DOACs have not been fully known.

Case Presentation: We herein present the case of a 64-year old male with the complaint of acute onset epistaxis and bleeding gums following the concomitant use of rivaroxaban and saffron supplement. It seems that coadministration of DOACs and saffron supplements should be avoided due to the potential drug-herbal interactions and possible risk of subsequent bleeding complications.

Conclusion: However, further larger-scale surveillance studies are needed to confirm the findings and assess the clinical significance.

Keywords: Direct oral anticoagulants, DOACs, rivaroxaban, saffron, crocin, epistaxis, bleeding gums.

[1]
Chan, N.; Sobieraj-Teague, M.; Eikelboom, J.W. Direct oral anticoagulants: Evidence and unresolved issues. Lancet, 2020, 396(10264), 1767-1776.
[http://dx.doi.org/10.1016/S0140-6736(20)32439-9] [PMID: 33248499]
[2]
Srivastava, R.; Ahmed, H.; Dixit, R.K. Dharamveer; Saraf, S.A. Crocus sativus L.: A comprehensive review. Pharmacogn. Rev., 2010, 4(8), 200-208.
[http://dx.doi.org/10.4103/0973-7847.70919] [PMID: 22228962]
[3]
Harrison, P. Platelet function testing; Waltham, MA, 2019.
[4]
Jámbor, C.; Weber, C.F.; Gerhardt, K.; Dietrich, W.; Spannagl, M.; Heindl, B.; Zwissler, B. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction. Anesth. Analg., 2009, 109(1), 25-31.
[http://dx.doi.org/10.1213/ane.0b013e3181a27d10] [PMID: 19439684]
[5]
Abdullah, W.Z.; Bakar, S.A.; Zain, W.S.W.M.; Yusof, Z.; Mustaffa, R.; Hassan, R. Aspirin effects on platelets using whole blood tested by platelet aggregometry: A comparative study for test validation in a clinical hemostasis laboratory. Lab. Med., 2013, 44(1), 90-96.
[http://dx.doi.org/10.1309/LM13UR8VGQTNCBVQ]
[6]
Zhang, H.Z.; Yu, L.H.; Kim, M.H. Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: A comparison between citrate and hirudin. Platelets, 2013, 24(5), 339-347.
[http://dx.doi.org/10.3109/09537104.2012.698431] [PMID: 22774770]
[7]
Jessie, S.W.; Krishnakantha, T.P. Inhibition of human platelet aggregation and membrane lipid peroxidation by food spice, saffron. Mol. Cell. Biochem., 2005, 278(1-2), 59-63.
[http://dx.doi.org/10.1007/s11010-005-5155-9] [PMID: 16180089]
[8]
Thushara, R.M.; Hemshekhar, M.; Santhosh, M.S.; Jnaneshwari, S.; Nayaka, S.C.; Naveen, S.; Kemparaju, K.; Girish, K.S. Crocin, a dietary additive protects platelets from oxidative stress-induced apoptosis and inhibits platelet aggregation. Mol. Cell. Biochem., 2013, 373(1-2), 73-83.
[http://dx.doi.org/10.1007/s11010-012-1476-7] [PMID: 23065381]
[9]
Sinakosa, Z.M.; Geromichalosb, G.D. The effect of saffron (Crocus sativus) carotenoids on hemostasis and atherosclerosis. Next Gener. Seq. Appl., 2016, 3(1), 127.
[http://dx.doi.org/10.4172/2469-9853.1000127]
[10]
Modaghegh, M.H.; Shahabian, M.; Esmaeili, H.A.; Rajbai, O.; Hosseinzadeh, H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine, 2008, 15(12), 1032-1037.
[http://dx.doi.org/10.1016/j.phymed.2008.06.003] [PMID: 18693099]
[11]
Steffel, J.; Collins, R.; Antz, M.; Cornu, P.; Desteghe, L.; Haeusler, K.G. European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace,, 2021, 2021.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy